AnaptysBio, Inc. (ANAB) Social Stream
Anaptysbio Inc (ANAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Anaptysbio Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ANAB's average price target has moved up $17.57 over the prior 23 months.
ANAB reports an average of 30.07% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ANAB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, ANAB's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Anaptysbio Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -480.14% of that group.
- In the context of Pharmaceutical Products stocks, Anaptysbio Inc's upside potential (average analyst target price relative to current price) is higher than 138.58% of them.
- Anaptysbio Inc's number of analysts covering the stock is greater than 241.37% of stocks in the mid market cap category.
- ANAB has a greater average analyst price target than 405.75% of Pharmaceutical Products stocks.
What is the outlook for ANAB? Use POWR Ratings for clearer insight into price direction.